SDE-100 a stochastic cysteine linked Vedotin ADC: Assessing comparability of extent and site of conjugation using multiple orthogonal analytical approaches

Poster Presentation1 min read 28th Apr 2023

Share via email Share via LinkedIn

Download resource

Share via email Share via LinkedIn

Popular articles

Webinar17 min watch

Residual toxin removal from ADCs: Scale and phase appropriate approaches and challenges Read more

One pager4 min read

Double trouble: Competitive alkylation and LCMS analysis for efficient screening of dual payload ADCs Read more

Preview of Sterling Pharma Solutions' ADC case study about a project involving DMA

Poster Presentation8 min read

When ADC meets DMA: Uncovering unexpected critical parameters Read more

Preview of Sterling Pharma Solutions' ADC case study about a Veraxa project

Poster Presentation6 min read

Transfer, simplify, scale: ADC partnership development Read more

ADC manufacturing facilities at Sterling Pharma Solutions' Deeside, Wales facilities

Blog7 min read

Top 5 considerations in ADC clinical manufacturing Read more

Molly Monahan - Production Supervisor

Spotlight4 min read

Sterling Snapshot | Molly Monahan, Production Supervisor Read more

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

URL

This field is for validation purposes and should be left unchanged.

Name(Required)

Email(Required)

Company Name(Required)

This field is hidden when viewing the form

Prospect Source

Please click here for our privacy policy

Service. Passion. Science.

PDMO^® is registered in the U.S. Patent and Trademark Office.

PDMO^® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Dudley Lane, Dudley, Cramlington, NE23 7QG, United Kingdom. Registered in England.
VAT number: GB320549229